Scarica l'app Stockscreener
5.72
3.21%
-0.19
Precedente Chiudi:
$5.91
Aprire:
$5.13
Volume 24 ore:
410.58K
Relative Volume:
1.49
Capitalizzazione di mercato:
$11.76M
Reddito:
-
Utile/perdita netta:
$-16.31M
Rapporto P/E:
-10.59
EPS:
-0.54
Flusso di cassa netto:
$-7.46M
1 W Prestazione:
+56.97%
1M Prestazione:
+20.01%
6M Prestazione:
+3.55%
1 anno Prestazione:
-62.86%
Intervallo 1D:
$4.80
$5.96
Intervallo di 1 settimana:
$2.31
$6.69
Portata 52W:
$2.31
$15.40
Coeptis Therapeutics Holdings Inc Stock (COEP) Company Profile
Nome
Coeptis Therapeutics Holdings Inc
Settore
Industria
Telefono
724-934-6467
Indirizzo
105 BRADFORD ROAD, SUITE 420, WEXFORD
Confronta COEP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COEP
COEPTIS THERAPEUTICS INC
|
0.415 | 2.70M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.29 | 631.00M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.65 | 372.90M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
0.82 | 278.60M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
3.01 | 128.33M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
3.65 | 47.41M | 0 | 0 | 0 | 0.00 |
Coeptis Therapeutics Holdings Inc Borsa (COEP) Ultime notizie
Stock market today: Heartcore Enterprises -20.07%, Caravelle International -16.63% among biggest losers in early trading - Business Upturn
Coeptis Therapeutics (COEP) Stock Gains Pre-Hour Traction - Stocks Telegraph
Coeptis Therapeutics Holdings, Inc. Adds Autoimmune Indications to Exclusive License Agreement with University of Pittsburgh for SNAP-CAR T and SNAP-CAR NK - Marketscreener.com
PHLX Swiss Franc (XDS) QuotePress Release - The Globe and Mail
S&P 500 Growth (IGX) QuotePress Release - The Globe and Mail
Nasdaq Biotechnology Index (NBI) QuotePress Release - The Globe and Mail
KBW Property & Casualty Index (KPX) QuotePress Release - The Globe and Mail
Trading Halt Occurred During This Micro Cap's EOY Surge - MSN
Midday Market Movers: Biggest Stock Declines of the Day – Stock Market - HPBL
Stock market news: Coeptis Therapeutics Holdings -96.03%, OptiNose -93.07% among biggest losers during mid day trading - Business Upturn
Stock market news: Coeptis Therapeutics Holdings declined by 96.03% whereas Baird Medical Investment Holdings +496.89% during mid day trading - Business Upturn
Stock market today: Coeptis Therapeutics Holdings -95.79%, OptiNose -93.64% among biggest losers in early trading - Business Upturn
Stock market today: Coeptis Therapeutics Holdings plunged by 95.98% whereas Baird Medical Investment Holdings gained over 201.90% in early trading - Business Upturn
Coeptis Therapeutics announces reverse stock split plan to remain on the Nasdaq - The Business Journals
Why Is Coeptis Therapeutics Stock Falling On Friday? - Yahoo Finance
Coeptis Therapeutics Announced an Acquisition and a New Divison Launch - Martechcube
Coeptis Therapeutics announces reverse stock split - MSN
Coeptis Therapeutics Announces Reverse Stock Split - Lelezard
Coeptis Therapeutics announces 1-for-20 reverse stock split - Investing.com
Coeptis Therapeutics (COEP) Announces 1-for-20 Reverse Stock Split to Maintain Nasdaq Listing - StockTitan
Coeptis expands with AI platform acquisition and new tech division By Investing.com - Investing.com Canada
Coeptis Therapeutics Announces Reverse Stock Split (PR Newswire) - Aktiellt
Coeptis Therapeutics completes acquisition of AI company, launching technology division - The Business Journals
Coeptis Therapeutics Holdings, Inc. completed the acquisition of NexGenAI Affiliates Network from NexGenAI Solutions Group, Inc. - Marketscreener.com
Stock market today: Millennium Group International surged by 318.96% while SciSparc increased by 153.01% in early trading - Business Upturn
Coeptis expands with AI platform acquisition and new tech division - Investing.com
Coeptis Therapeutics Makes Bold Strides in Innovation with the Acquisition of NexGenAI Affiliates Network Platform and Launch of Coeptis Technologies - Citizentribune
Coeptis Therapeutics Holdings, Inc. Reports Voting Results from Annual Meeting - Defense World
COEP Stock Plummets to 52-Week Low at $0.15 Amid Market Challenges - Investing.com Canada
Short Interest in Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) Increases By 11.0% - Defense World
Financial Comparison: Coeptis Therapeutics (NASDAQ:COEP) & PharmaCyte Biotech (NASDAQ:PMCB) - Defense World
Coeptis launching technology division with AI and data security-focused acquisitions - The Business Journals
Coeptis Launches New Technology Division - Contract Pharma
Coeptis Therapeutics Unveils New Technology Division: Coeptis Te - GuruFocus.com
Coeptis Therapeutics launches tech division, eyes data security - Investing.com
Coeptis Therapeutics Unveils New Technology Division: Coeptis Technologies - Marketscreener.com
Why DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket - Benzinga
Coeptis Therapeutics Expands License Agreement with Deverra to Include Pandemic Preparedness, and Emergency Use - The Eastern Progress Online
Coeptis Therapeutics to Acquire NexGenAI for Enhanced AI Tools By Investing.com - Investing.com South Africa
Coeptis Therapeutics Holdings to Acquire NexGenAI Affiliates Network, - citybiz
Coeptis Therapeutics to Acquire NexGenAI for Enhanced AI Tools - Investing.com India
Coeptis Acquires AI-Powered Marketing Platform - Contract Pharma
Coeptis Therapeutics takes steps to acquire NexGenAI Affiliates Network - The Business Journals
Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries - PR Newswire
Could BigBear.ai Become the Next Palantir Technologies? - AOL
Tesla stock could drop 35% as the Trump-fueled rally isn't supported by business fundamentals, UBS says - AOL
Coeptis Therapeutics Expands License Agreement with Deverra to I - GuruFocus.com
Coeptis Therapeutics Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Armistice Capital, LLC's Strategic Acquisition in Coeptis Therap - GuruFocus.com
Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development - Quantisnow
Coeptis broadens NK cell tech license for emergency use - Investing.com India
Coeptis Therapeutics Holdings Inc Azioni (COEP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Coeptis Therapeutics Holdings Inc Azioni (COEP) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| DeSilva Tara | Director |
Jan 12 '24 |
Buy |
0.58 |
2,266 |
1,305 |
32,266 |
| Yerace Daniel Alexander | VP of Operations |
Jan 05 '24 |
Buy |
0.69 |
10,850 |
7,486 |
1,071,455 |
| Salkind Gene | Director |
Jan 05 '24 |
Buy |
0.69 |
11,600 |
8,004 |
284,056 |
| Mehalick David | CEO and President |
Jan 08 '24 |
Buy |
0.66 |
20,004 |
13,263 |
2,782,615 |
| Mehalick David | CEO and President |
Jan 05 '24 |
Buy |
0.69 |
5,050 |
3,484 |
2,762,611 |
| Cochran Christopher P. | Director |
Jan 05 '24 |
Buy |
0.77 |
7,000 |
5,390 |
37,000 |
0.60%
2.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):